Deferred Tax Assets
Gilead Sciences Deferred Tax Assets decreased by 55.5% to $179.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 74.8%, from $709.00M to $179.00M. Over 4 years (FY 2021 to FY 2025), Deferred Tax Assets shows a downward trend with a -39.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase can signal future tax efficiency or the utilization of past losses, while a decrease may indicate the realization of those benefits.
Detailed definition
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between the...
Peer comparison
Common in large, capital-intensive companies; peers with significant R&D spending often have large deferred tax assets from tax credits.
deferred_tax_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.37B | $4.60B | $4.36B | $3.69B | $3.36B | $3.04B | $2.67B | $2.40B | $2.11B | $1.98B | $1.59B | $933.00M | $907.00M | $794.00M | $724.00M | $709.00M | $652.00M | $597.00M | $402.00M | $179.00M |
| QoQ Change | — | +5.2% | -5.4% | -15.4% | -8.8% | -9.8% | -12.0% | -10.2% | -12.3% | -5.8% | -20.0% | -41.2% | -2.8% | -12.5% | -8.8% | -2.1% | -8.0% | -8.4% | -32.7% | -55.5% |
| YoY Change | — | — | — | — | -23.1% | -34.0% | -38.6% | -34.9% | -37.4% | -34.7% | -40.6% | -61.1% | -56.9% | -60.0% | -54.4% | -24.0% | -28.1% | -24.8% | -44.5% | -74.8% |
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's deferred tax assets?
- Gilead Sciences (GILD) reported deferred tax assets of $179.00M in Q1 2026.
- How has Gilead Sciences's deferred tax assets changed year-over-year?
- Gilead Sciences's deferred tax assets decreased by 74.8% year-over-year, from $709.00M to $179.00M.
- What is the long-term trend for Gilead Sciences's deferred tax assets?
- Over 4 years (2021 to 2025), Gilead Sciences's deferred tax assets has grown at a -39.7% compound annual growth rate (CAGR), from $17.80B to $2.36B.
- What does deferred tax assets mean?
- Future tax savings that the company expects to realize due to past accounting differences or tax losses.